Replies to post #379837 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Dr. Christopher U. Missling MS PhD MBA as the Chairman and CEO of Anavex Life Sciences may want to accept the applause and accolades from the audience on the part of everyone involved in the trial.

Good luck and GOD bless,

[scratchy]

Mac Farlane is a scientist, he’s going to CTAD no matter what. If it’s bad to good results he’ll be presenting his work, if it’s exceptional, Chris might want to “jump in” on behalf of Anavex although I doubt it.

Scientist present their work in order to advance the science although it’s more enjoyable to present good results, there’s knowledge to be gained from bad ones as well.

Either way we can’t tell from his response, and I’m ok with that.

[James salmon]

I will go with what the PR said;

“Top Line Data of ANAVEX®2-73 (blarcamesine) Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2b/3 in Patients with Early Alzheimer’s Disease (AD)
Date / Time: December 1, 2022 / 4:30pm PT
Presenter: A/Prof. Stephen Macfarlane, Principal Investigator
Session Title: LB8 - LATE BREAKING ORAL COMMUNICATIONS”